Merilog is a rapid-acting human insulin analog designed to reduce spikes ... This approval extends to a 3-milliliter single-patient-use prefilled pen and a 10-milliliter multiple-dose vial ...

NovoLog is also available in pen injector formats ... having a biosimilar option for their rapid-acting insulin injection can truly make a difference, as biosimilar products have the potential ...

Sanofi’s Admelog (insulin lispro) is approved in type 1 and type 2 diabetes as a follow-on drug to Humalog, a rapid-acting insulin ... form or as a disposable pen. Sanofi fights back This ...

You use a needle or pen device to give yourself the injection. Be sure to inject your long-acting insulin at the ... A doctor might recommend adding rapid insulin before a meal to prevent a ...

The US Food and Drug Administration approved the first-ever rapid-acting insulin for reducing blood ... s 3-milliliter single-patient-use prefilled pen and a 10-milliliter multiple-dose vial.

Insulin lispro, the rapid-acting component of Humalog Mix75/25 ... Do not reuse or share pens, needles, cartridges, or syringes between patients, even if the needle is changed.

Patients received the FlexPen if they were randomized to the insulin pen group and prescribed any rapid-acting insulin (insulin lispro or insulin aspart) or the combination of 70% insulin aspart ...

NovoPen ®, the first insulin pen injector, was introduced in 1985. This article reviews the published evidence over two decades of use of the NovoPen ® family of injection devices in diabetes ...

In 1999, we introduced rapid-acting and, in 2004, long-acting insulin analogues produced by ... we introduced the world’s first pen-shaped devices for subcutaneous injection in 1985.